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Abstract
Significant advances have been made in the discovery of genes affecting bone mineral density (BMD); however, our
understanding of its genetic basis remains incomplete. In the current study, genome-wide association (GWA) and co-
expression network analysis were used in the recently described Hybrid Mouse Diversity Panel (HMDP) to identify and
functionally characterize novel BMD genes. In the HMDP, a GWA of total body, spinal, and femoral BMD revealed four
significant associations (2log10P.5.39) affecting at least one BMD trait on chromosomes (Chrs.) 7, 11, 12, and 17. The
associations implicated a total of 163 genes with each association harboring between 14 and 112 genes. This list was
reduced to 26 functional candidates by identifying those genes that were regulated by local eQTL in bone or harbored
potentially functional non-synonymous (NS) SNPs. This analysis revealed that the most significant BMD SNP on Chr. 12 was a
NS SNP in the additional sex combs like-2 (Asxl2) gene that was predicted to be functional. The involvement of Asxl2 in the
regulation of bone mass was confirmed by the observation that Asxl2 knockout mice had reduced BMD. To begin to unravel
the mechanism through which Asxl2 influenced BMD, a gene co-expression network was created using cortical bone gene
expression microarray data from the HMDP strains. Asxl2 was identified as a member of a co-expression module enriched for
genes involved in the differentiation of myeloid cells. In bone, osteoclasts are bone-resorbing cells of myeloid origin,
suggesting that Asxl2 may play a role in osteoclast differentiation. In agreement, the knockdown of Asxl2 in bone marrow
macrophages impaired their ability to form osteoclasts. This study identifies a new regulator of BMD and osteoclastogenesis
and highlights the power of GWA and systems genetics in the mouse for dissecting complex genetic traits.
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Introduction
Osteoporosis is a common disease characterized by bone
fragility and an increased risk of fracture [1]. One of strongest
predictors of fracture is low bone mineral density (BMD) [2] and
while BMD is influenced by both genetic and environmental
factors, most (between 60% and 80%) of its variance is heritable
[3]. Thus, the identification of novel BMD genes is critical for the
discovery of new pathways and gene networks that will advance
our understanding of basic bone biology and identify new
therapeutic targets with the potential to combat osteoporosis.
Due in large part to its many advantages, such as the ability to
experimentally cross genetically defined strains and perturb
candidate genes, the mouse has played an instrumental role in
the genetic analysis of BMD [4]. However, progress has been
limited by low-resolution linkage-based quantitative trait loci
(QTL) mapping approaches and the difficulties inherent to QTL
cloning [5]. As a result, mouse linkage approaches have lead to the
identification of only three BMD quantitative trait genes, Alox12
[6], Sfrp4 [7] and Darc [8], even though hundreds of QTL have
been mapped [9]. In part due to the success of genome-wide
association (GWA) in humans, several groups have investigated the
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the mouse. One of the main challenges facing GWA in the mouse
has been determining the most ideal population for such analyses.
To date, mouse GWA studies have been performed with varying
success using small sets of classical laboratory strains [10],
advanced intercross lines [11], heterogeneous stocks [12], outbred
mice [13,14] and the Hybrid Mouse Diversity Panel (HMDP)
[15]. One of the most promising is the HMDP, a collection of
,100 classical laboratory and recombinant inbred (RI) strains that
have been genotyped at ,135,000 SNPs [15]. The primary
advantage of the HMDP is that mapping resolution is over an
order of magnitude higher than with linkage. We have recently
demonstrated through simulations that associations explaining 5%
of the phenotypic variance in a trait have 95% confidence intervals
(CIs) of ,2.6 megabases (Mb) [15]. This is in comparison to CIs
for mouse linkage studies that are typically in the range of 40–
60 Mb [13]. Additionally, statistical power in the HDMP has been
found to be adequate to map variants affecting complex traits [15].
Moreover, phenotypes can be mapped in the HMDP without the
need for costly genotyping and one can collect multiple specimens
(e.g. tissues, individual cell-types, etc.) from strains for molecular
profiling that are difficult or impossible to collect from a single
mouse [15].
A drawback of both mouse and human GWA studies (and all
‘‘genotype to phenotype’’ mapping approaches) is their inability to
provide information on how associated genes actually influence
disease [16]. In many cases, it takes years to decipher the
underlying biology of novel gene discoveries. One way to begin to
provide functional information is through the use of systems
genetics [17]. Systems genetics is an approach that incorporates
molecular phenotypes, most commonly gene expression micro-
array profiles, into the genetic analysis of clinical phenotypes. One
way that systems genetics can be used to functionally annotate
genes of unknown function is through the generation of gene co-
expression networks. Co-expression networks are created by
clustering genes based on patterns of co-expression across a series
of perturbations, such as the differing genetic backgrounds in the
HMDP [18]. Co-expressed gene clusters or ‘‘modules’’ have been
shown to be enriched for genes involved in the same general
function [19,20,21], allowing one to annotate genes through
‘‘guilt-by-association’’ [22]. For example, if an uncharacterized
gene is co-expressed with genes known to be involved in a
biological process such as ‘‘apoptosis’’, then it is more likely than
not the unknown gene is also involved in ‘‘apoptosis’’. The use of
network analysis of systems genetic data can help to inform GWA
discoveries by providing clues as to a gene’s function in a
physiologically-relevant context.
The goal of the current study was to identify and functionally
characterize novel BMD genes using GWA and systems genetics in
the HMDP. This approach implicated additional sex combs like-2
(Asxl2) as the gene responsible for a BMD association on
chromosome (Chr.) 12. This was further strengthened by the
observation that Asxl2 knockout mice had reduced BMD.
Furthermore, gene co-expression analysis of bone transcriptomic
data predicted that Asxl2 was involved in the differentiation of
bone-resorbing osteoclasts. In support of this prediction, osteo-
clastogenesis was impaired in bone marrow macrophages in which
Asxl2 expression was reduced by RNA interference. Together,
these data are consistent with the hypothesis that Asxl2 is a novel
regulator of BMD and osteoclastogenesis.
Results
Genome-wide association analysis of BMD in the HMDP
A detailed description of the HMDP, including strain selection
and evaluation of statistical power and mapping resolution, is
provided in [15]. Towards identifying genomic regions associated
with BMD, we phenotyped 16-week old male mice (N=879) from
97 HMDP strains (N=9.1 mice/strain) for total body (TBMD),
lumbar spine (SBMD) and femur (FBMD) areal BMD (Table S1).
A wide range of BMD values were observed across the HMDP
with differences of 1.4, 1.6 and 1.6-fold between the lowest and
highest strains for TBMD, SBMD and FBMD, respectively
(Figure 1).
To identify associations for the three BMD phenotypes we used
the Efficient Mixed-Model Association (EMMA) algorithm [23].
Adjusted association P-values were calculated for 108,064 SNPs
with minor allele frequencies .5%. We have previously demon-
strated that the P,0.05 genome-wide equivalent for GWA using
EMMA in the HMDP is P=4.1610
26 (2log10P=5.39) [23]. At
this threshold, associations on chromosomes (Chrs.) 7, 12 and 17
were identified influencing TBMD (Figure 2A). A fourth unique
association on Chr. 11 was identified for SBMD (Figure 2B) and the
only significant locus for FBMD was the Chr. 7 association also
affecting TBMD (Figure 2C). The details of each association are
providedin Table 1. Importantly,eachofthese regions overlap with
the location of QTL for areal BMD measures previously identified
by linkage in F2 crosses [9].
Characterization of BMD associations
We have previously shown that the 95% confidence interval
(CI) for the distribution of distances between the most significant
and true causal SNPs, for simulated associations that explain 5%
of the variance in the HMDP, is ,2.6 Mb [24]. Therefore, we
used this interval to conservatively define the boundaries of the
four associations (Table 1). Within each association there were a
total of 112 (Chr. 7), 14 (Chr. 11), 18 (Chr. 12) and 19 (Chr. 17)
unique RefSeq genes (a full list of genes is provided in Table S2).
We next identified those genes possessing functional alterations
that might underlie the associations. Genes were selected based on
whether they were regulated by a local expression QTL (eQTL) in
the HMDP or if they harbored a non-synonymous (NS) SNP that
was predicted to have functional consequences. For the eQTL
analysis, we generated gene expression microarray profiles using
RNA isolated from cortical bone in 95 of the 97 HMDP strains
(N=1–3/arrays per strain). EMMA was then used to perform an
association analysis between all SNPs and array probes mapping
Author Summary
Osteoporosis is a disease of weak and fracture-prone
bones. The characteristic of bone that is most predictive of
fractures is low bone mineral density (BMD), a trait
primarily controlled by genetics. In recent years, significant
advances have been made in the discovery of genes
affecting BMD; however, our understanding of its genetic
basis is still primitive. In this study, we used genome-wide
association in the mouse to identify additional sex combs
like-2 (Asxl2) as a novel BMD gene. In confirmation of our
genetic analysis, mice deficient in Asxl2 had reduced BMD.
To evaluate its function in bone, the expression levels of
Asxl2 and tens of thousands of other genes were measured
in bone in a large number of inbred mouse strains. Asxl2
demonstrated a pattern of expression indicative of genes
that play a critical role in osteoclasts, the cells that are
responsible for bone resorption. Further study of Asxl2
may reveal novel therapeutic targets for the treatment and
prevention of osteoporosis.
Association and Systems Genetics Analysis of BMD
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one probe, after excluding probes that overlapped SNPs present
among the classical inbred strains used in the HMDP (see
Methods). Of these, 11 genes (8 within the Chr. 7 association and
3 within the Chr. 17 association) were identified with at least
one probe whose expression was regulated by a significant
(P#5.1610
24; Bonferroni corrected for the number of probes
tested) local eQTL (Table 2 and data for all genes is provided in
Table S2). In addition, we identified a total of 19 NS SNPs in 14
genes that were predicted to be either ‘‘Possibly Damaging’’ or
‘‘Probably Damaging’’ by PolyPhen [25,26] (Table 3 and a list of
all NS SNPs is provided in Table S3). A nonsense SNP was also
identified in the meprin A, alpha (Mep1a) gene (Table 3).
Therefore, of the 163 positional candidate genes, 26 were found
to be regulated by a local eQTL in bone or harbored potentially
functional NS SNPs. The number of functional candidate genes
within each association was 12 (Chr. 7), 2 (Chr. 11), 3 (Chr. 12)
and 9 (Chr. 17).
We also determined if any of the 163 genes implicated by GWA
have been previously implicated in bone development. The
associations on Chrs. 11 and 12 did not harbor known bone
genes. In contrast, three (Fosb [27], RelB [28] and Apoe [29]) of the
Chr. 7 genes have been linked to the regulation of bone mass. All
three were located in close proximity to the association peak. Fosb
was 124 kilobases (Kb) upstream, Relb was 180 Kb downstream
and Apoe was 270 Kb downstream of rs32149600, the most
significantly associated SNP on Chr. 7. Additionally, of the 19
Chr. 17 genes, Runx2, the ‘‘master regulator’’ of osteoblast
Figure 1. Characterization of bone mineral density (BMD) in the HMDP. Mean6SEM for (A) total body (TBMD), (B) spine (SBMD) and (C)
femur (FBMD) BMD (g/cm
2) in 97 HMDP inbred mouse strains. Differences between the strains with the lowest and highest values were 1.4, 1.6 and
1.6-fold for TBMD, SBMD and FBMD, respectively.
doi:10.1371/journal.pgen.1002038.g001
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rs33294019, the most significant SNP. None of the known bone
genes were regulated by local bone eQTL or harbored potentially
functional NS SNPs.
Detailed analysis of the Chr. 12 association implicates
Asxl2 as a regulator of BMD
All 26 of the genes identified above are candidates for the BMD
associations and warrant further investigation. However, the goal
of this analysis was to identify a gene(s) that was the most likely
causal gene for an association. Due to Chr. 7 and Chr. 17
possessing multiple functional candidates (12 and 9, respectively),
we could not identify the most likely candidate based on the
existing data for either of the associations; therefore, we focused on
the Chr. 11 and Chr. 12 associations due to the presence of only 2
and 3 functional candidates, respectively. All five of these genes
harbored potentially functional NS SNPs. The expression of these
genes was not regulated by local eQTL. Of the five, the additional
sex-combs like 2 (Asxl2) was the most compelling candidate due to
the fact that rs29131970, a NS SNP in Asxl2 that was predicted to
be functional, was also the peak SNP for Chr. 12 BMD association
(Table 3 and Figure 3). Rs29131970 results in a phenylalanine (F)
to serine (S) substitution at amino acid 1191 of the mouse ASXL2
Figure 2. GWAS results for BMD in the HMDP. Manhattan plots showing the 2log10 of the association P-values (2logP) for (A) total body
(TBMD), (B) spine (SBMD) and (C) femur (FBMD) in 97 HMDP strains. The analysis was performed using 108,064 SNPs with a minor allele frequency
.5%. Each mouse chromosome is plotted on the x-axis in alternating dark and light blue colors. SNPs in red on Chrs. 7, 12 and 17 for TBMD, Chr. 11
for SBMD and Chr. 7 for FBMD exceeded the predetermined genome-wide significance threshold of 2logP=5.39.
doi:10.1371/journal.pgen.1002038.g002
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harbors the ‘‘C’’ allele, which codes for S; whereas, the rat,
human, orangutan, dog, horse, opossum and chicken reference
genomes all have the ‘‘T’’ allele, which codes for F. HMDP strains
homozygous for the ‘‘C’’ allele had lower BMD relative to strains
with the ‘‘T’’ allele (data not shown). A role for the other four
candidates possessing NS SNPs on Chr. 11 and Chr. 12 appear to
be less likely because of the modest linkage disequilibrium (LD) (r
2
between 0.09 and 0.36) among the HMDP classical inbred strains
between these SNPs and the SNPs most significantly associated
with BMD for each region (Table 3). Therefore, based on the
existing data we hypothesized that Asxl2 was the causal gene for
the Chr. 12 association.
Asxl2 knockout mice have reduced BMD
To directly test the hypothesis that Asxl2 was involved in the
regulation of BMD we characterized TBMD, SBMD and FBMD
in Asxl2 knockout mice (Asxl2
2/2). The mice used for this
experiment were between the ages of 2–4 months and as
previously reported [31] a significant (P,0.05) reduction in body
weight in Asxl2
2/2 mice was observed (data not shown). To
evaluate bone mass in the absence of these confounding effects we
evaluated the BMD residuals across genotype after adjusting for age
and body weight within each sex. This analysis revealed significant
(P,0.05) reductions in TBMD, SBMD and FBMD residuals in
male Asxl2
2/2 mice as compared to wild-type (Asxl2
+/+)
controls (Figure 4A–4C). In addition, male heterozygous (Asxl2
+/2)
mice demonstrated an intermediate phenotype for all BMD
measures, although the differences were not statistically different
from either homozygous genotype (Figure 4A–4C). We also
observed similar decreases in TBMD, SBMD and FBMD residuals
in female Asxl2
2/2 mice as compared to Asxl2
+/+ controls
(Figure 4D–4F). These data confirm that Asxl2 is a regulator of
BMD and are consistent with the hypothesis that Asxl2 is
responsible for the genetic association on Chr. 12 in the HMDP.
Transcriptional network analysis predicts that Asxl2 is
involved in osteoclastogenesis
We next used systems genetics to begin to identify a potential
function for Asxl2 in bone. For this analysis we utilized the cortical
bone gene expression data from the HMDP strains. An analysis of
Asxl2 expression revealed that while its expression was not under
regulation by detectable local (described above) or distant eQTL
(data not shown), Asxl2 was expressed in cortical bone (in the top
10% of probes based on average expression) and most important-
ly, its expression differed by 1.5-fold between the lowest and
highest expressing HMDP strains (Figure S1). We reasoned that its
high level of expression and variation in expression among strains
would allow us to identify biologically meaningful co-expression
relationships between Asxl2 and genes sharing similar functions,
even though a difference in its expression does not underlie the
Chr. 12 association. To identify the genes that were co-expressed
with Asxl2 in bone, genes were grouped into ‘‘co-expression
modules’’ using Weighted Gene Co-expression Network Analysis
(WGCNA) [20]. We used WGCNA to generate a bone co-
expression network comprised of the 3600 most variable and
highly connected genes (see Methods). The 3600 genes were
subsequently partitioned into eight gene modules (Figure 5A). Of
the eight, we focused our attention on the blue module that
contained Asxl2 along with 1334 other genes (full list is provided in
Table S4). The DAVID knowledge base (http://david.abcc.
ncifcrf.gov/) was used to determine if the blue module was
enriched for specific gene ontology (GO) categories. We were most
interested in identifying enrichments in specific gene functions;
thus, we restricted the analysis to the GO biological process and
molecular function categories and excluded the cellular compo-
Table 1. GWA results for BMD in the HMDP.
Traita Chr SNP
Position
(Mb)b 2logP MAFc 95% CI (Mb)
b
No. of
genesd
Human Region
(Chr: Start Mb – End Mb)
Start Stop
TBMD 7 rs32149600 20.01 6.60 0.12 18.71 21.31 92 Chr19:49.7–51.2
FBMD 7 rs32149600 20.01 5.59 0.12 18.71 21.31 92 Chr19:49.7–51.2
SBMD 11 rs26963925 56.77 5.60 0.41 55.47 58.07 14 Chr5:151.3–154.3
TBMD 12 rs29131970 3.50 5.77 0.13 2.20 4.80 17 Chr2:24.2–26.2
TBMD 17 rs33294019 43.91 7.35 0.15 42.61 45.21 19 Chr6:44.9–48.0
aTBMD, total body BMD; FBMD, femur BMD; SBMD, spine BMD.
bLocations based on NCBI’s Build37 genome assembly.
cMAF, minor allele frequency.
dNumber of RefSeq genes located in the mouse association CI based on genome annotation from NCBI’s Build37 assembly.
doi:10.1371/journal.pgen.1002038.t001
Table 2. Genes within BMD associations regulated by local
eQTL in bone.
Gene RefSeq Chr
txStart
(bp)
a
txEnd
(bp)
b
Local
eQTL P
Pglyrp1 NM_009402 7 19470038 19475787 1.3610
24
Irf2bp1 NM_178757 7 19589413 19592112 3.9610
28
Dmwd NM_010058 7 19661548 19668124 1.8610
214
Six5 NM_011383 7 19679892 19683694 6.5610
25
Ercc2 NM_007949 7 19967387 19981041 2.7610
24
Bloc1s3 NM_177692 7 20091152 20093680 2.5610
25
Trappc6a NM_025960 7 20094077 20101494 1.6610
27
Gemin7 NM_027189 7 20150297 20158692 8.0610
26
Tnfrsf21 NM_178589 17 43153503 43226137 1.66102
14
Cyp39a1 NM_018887 17 43804373 43888380 4.6610
218
Rcan2 NM_207649 17 43938799 44176465 1.3610
24
atxStart, location of transcription start based on NCBI Build37 genome
assembly.
btxEnd, location of transcription end based on NCBI Build37 genome assembly.
doi:10.1371/journal.pgen.1002038.t002
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SNP Chr Location (bp)
a Alleles
b dbSNP_ann
c PolyPhen
d r
2e
rs32410945 7 19943262 C/G Cd3eap:Cn:RG:89 Possibly Damaging 0.13
rs32422546 7 20288622 A/G Tomm40:Cn:HY:204 Probably Damaging 0.31
rs13465077 7 20370636 A/G Cblc:Cn:DG:415 Possibly Damaging 0.64
rs49286080 7 20555548 C/G Ceacam20:Cn:HQ:57 Possibly Damaging 0.85
rs47432737 7 20555772 C/T Ceacam20:Cn:TI:132 Possibly Damaging 0.85
rs46058112 7 20561620 G/T Ceacam20:Cn:GC:406 Possibly Damaging 0.42
rs26966327 11 57953077 C/G Gemin5:Cn:SC:807 Possibly Damaging 0.15
rs26950310 11 58001304 C/T Irgb10:Cn:TM:14 Possibly Damaging 0.15
rs51508182 12 3501078 C/T Asxl2:Cn:TI:939 Possibly Damaging 0.36
rs29131970 12 3501831 C/T Asxl2:Cn:SF:1190 Probably Damaging 1.00
rs48727919 12 4216641 A/C Cenpo:Cn:VF:155 Probably Damaging 0.09
rs48755392 12 4722485 C/T 4930417G10Rik:Cn:HR:256 Possibly Damaging 0.36
rs13482992 17 42803796 A/G Gpr115:Cn:AV:534 Possibly Damaging 0.02
rs46389302 17 42846983 A/G Gpr111:Cn:SF:632 Probably Damaging 0.00
rs51535437 17 43578895 A/T Gpr116:Cn:DV:592 Probably Damaging 0.05
rs48412763 17 43628670 A/G Mep1a:Cn:Q*:150 Nonsense 0.05
rs51295335 17 43739797 A/C Pla2g7:Cn:ED:226 Probably Damaging 0.05
rs33536829 17 43761286 C/T Tdrd6:Cn:YC:1939 Probably Damaging 0.01
rs49026999 17 4376341 C/T Tdrd6:Cn:YC:1231 Possibly Damaging 0.05
rs45824990 17 43763779 C/T Tdrd6:Cn:HR:1108 Probably Damaging 0.06
aSNP location based on NCBI Build37 genome assembly.
bObserved alleles.
cdbSNP annotation given as Gene:snp effect:amino acid change relative to observed alleles: position in protein sequence.
dPolyphen prediction.
eLinkage disequilibrium (r2) between each SNP and the peak BMD SNP within its respective region.
doi:10.1371/journal.pgen.1002038.t003
Figure 3. Close-up view of the TBMD Chr. 12 association in the HMDP. Distal segment (proximal region was truncated because it was the
beginning of Chr. 12 and did not harbor any known or predicted genes) of the 2.6 Mb, 95% CI interval for the total body BMD (TBMD) association on
mouse Chr. 12. The blue diamond represents the most significant SNP. SNPs are colored based on their LD with the most significant SNP; orange SNPs
are in LD at r
2.0.6, yellow SNPs are in LD at r
2.0.4 and white SNPs are at r
2,0.4. The green shaded box approximates the extent of moderate LD
(r
2.0.6) and outlines the most likely position of the causal gene. The positions of all RefSeq genes are plotted at the bottom using genome locatins
from NCBI’s Build37 genome assembly. Directional green arrows indicate transcript orientation.
doi:10.1371/journal.pgen.1002038.g003
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used to identify 14 significant (enrichment score (ES) .3.0; see
Methods) gene clusters containing highly related GO terms (Table
S5). The top four clusters contained genes involved in: 1) the cell
cycle/chromosome/DNA replication/cell division, 2) hematopoi-
esis/myeloid cell differentiation, 3) ATP binding and 4) chromo-
some organization/chromatin organization (Table 4). Asxl2 is
thought to regulate the function of Polycomb (PcG) and Trithorax
(trxG) protein complexes, which are involved in the establishment
and maintenance of chromatin [31]. Its membership in a module
enriched for genes involved in the GO terms ‘‘chromosome’’
(Bonferroni corrected enrichment P=3.2610
27) and ‘‘chromatin
organization’’ (Bonferroni corrected enrichment P=9.2610
23)i s
consistent with its known function and suggests that this module is
comprised of biologically meaningful co-expression relationships.
We next characterized the nature of the genes most closely
connected to Asxl2 in the blue module. For this purpose, a network
view was generated for the 34,690 strongest connections among
1256 (94%) of the 1335 blue module genes (Figure 5B). In this
view of the blue module, Asxl2 was connected to a single node, the
apoptotic peptidase-activating factor 1 (Apaf1) gene. Apaf1, in turn,
was connected to 149 genes; all located within the cluster of genes
on the left side of the network depiction Figure 5B. To examine
the gene composition of the cluster connected to Asxl2, genes were
Figure 4. Mice deficient for Asxl2 have decreased BMD. Male mice deficient in Asxl2 (2/2) display significant decreases relative to wild-type
controls (+/+) in (A) TBMD, (B) SBMD and (C) FBMD residuals after adjusted for age and body weight. (B) Female mice deficient in Asxl2 (2/2) display
significant decreases relative to wild-type controls (+/+) in (D) TBMD, (E) SBMD and (F) FBMD residuals after adjusted for age and body weight. Data
shown in all panels are residual means6SEM. *P,0.05.
doi:10.1371/journal.pgen.1002038.g004
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PLoS Genetics | www.plosgenetics.org 7 April 2011 | Volume 7 | Issue 4 | e1002038Figure 5. Gene co-expression network analysis reveals that Asxl2 is connected to genes involved in myeloid cell differentiation. (A)
Gene co-expression network of the 3600 most variable and connected genes in the bone transcriptome. The network was created using Weighted
Gene Co-expression Network Analysis (WGCNA). Genes were plotted based on a dissimilarity metric (1-TOM). The low-hanging gene ‘‘branches’’ (each
gene is represented by a single line) are groups of genes that have highly similar TOMs (i.e. low dissimilarity). Based on the structure of each branch
genes are placed into a ‘‘module’’ of a particular color. Each branch’s color is labeled at the bottom of the panel. Asxl2 was a member of the blue
module. (B) Node and edge depiction of the 34,690 edges (i.e. connections between nodes or genes) with the highest TOM in the blue module
network. The blue module is enriched for genes involved in the cell cycle (green nodes), myeloid cell differentiation (red nodes) and chromatin
(yellow nodes). The blue square corresponds to Asxl2. Asxl2 is connected to one other gene, Apaf1; the orange node. Apaf1, in turn, is connected to
149 genes in the cluster of genes on the left side of the network. This group is enriched (P=2.0610
23) for genes involved in myeloid cell
differentiation (red nodes).
doi:10.1371/journal.pgen.1002038.g005
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enrichments described above, including the ‘‘cell cycle’’, ‘‘myeloid
cell differentiation’’ and ‘‘chromatin organization’’ (Table 4). We
excluded the ‘‘ATP-binding category’’ since genes in this category
are involved in a wide-range of biological processes. The blue
module as a whole was enriched for all three categories (Table 4);
however, the cluster of genes most closely connected to Asxl2
contained most (75%; enrichment P=2.0610
23) of the genes
involved in myeloid cell differentiation (red nodes in Figure 5B)
and very few cell cycle (green nodes) or chromatin organization
(yellow nodes) genes. These data indicate that in our bone
network, Asxl2 is most closely connected with genes involved in
myeloid cell differentiation and may play a role in this process.
Asxl2 is a regulator of osteoclastogenesis
The GO category ‘‘myeloid cell differentiation’’ is comprised of
genes that are involved in the general process of myeloid
precursors acquiring characteristics of downstream cell lineages.
With respect to bone cells, osteoclasts are bone-resorbing cells of
myeloid origin; thus, we hypothesized that Asxl2 played a role in
Table 4. Top four functional annotation clusters for the blue module.
Annotation Cluster 1: Enrichment Score=10.1
a Count
b %
c FE
d P-value
e
GO:0007049,cell cycle 105 8.2 2.6 6.8610
216
GO:0051301,cell division 55 4.3 2.9 4.0610
29
GO:0000278,mitotic cell cycle 48 3.7 2.9 1.1610
27
GO:0022402,cell cycle process 63 4.9 2.4 5.9610
27
GO:0022403,cell cycle phase 55 4.3 2.5 1.9610
26
GO:0000087,M phase of mitotic cell cycle 39 3.0 3.0 5.0610
26
GO:0048285,organelle fission 39 3.0 2.9 7.8610
26
GO:0007067,mitosis 38 3.0 3.0 9.6610
26
GO:0000280,nuclear division 38 3.0 3.0 9.6610
26
GO:0000279,M phase 47 3.7 2.5 5.2610
25
Annotation Cluster 2: Enrichment Score=8.4
GO:0030218,erythrocyte differentiation 19 1.5 5.9 2.0610
26
GO:0002376,immune system process 100 7.8 1.9 2.2610
26
GO:0030097,hemopoiesis 46 3.6 2.7 3.2610
26
GO:0034101,erythrocyte homeostasis 19 1.5 5.5 6.3610
26
GO:0002520,immune system development 50 3.9 2.5 8.6610
26
GO:0048534,hemopoietic or lymphoid organ development 48 3.7 2.5 1.4610
25
GO:0030099,myeloid cell differentiation 25 1.9 3.9 3.8610
25
GO:0048872,homeostasis of number of cells 25 1.9 3.3 1.0610
23
Annotation Cluster 3: Enrichment Score=8.0
GO:0032553,ribonucleotide binding 182 14.2 1.6 6.2610
28
GO:0032555,purine ribonucleotide binding 182 14.2 1.6 6.2610
28
GO:0017076,purine nucleotide binding 187 14.5 1.6 1.0610
27
GO:0000166,nucleotide binding 209 16.3 1.5 2.8610
27
GO:0032559,adenyl ribonucleotide binding 148 11.5 1.6 6.0610
26
GO:0005524,ATP binding 146 11.4 1.6 8.8610
26
GO:0030554,adenyl nucleotide binding 153 11.9 1.6 1.0610
25
GO:0001883,purine nucleoside binding 153 11.9 1.6 1.8610
25
GO:0001882,nucleoside binding 153 11.9 1.5 2.7610
25
GO:0016301,kinase activity 90 7.0 1.7 3.7610
24
GO:0016772,transferase activity, transferring phosphorus-containing groups 98 7.6 1.6 2.3610
23
GO:0016773,phosphotransferase activity, alcohol group as acceptor 72 5.6 1.6 4.5610
22
Annotation Cluster 4: Enrichment Score=6.1
GO:0051276,chromosome organization 65 5.1 2.4 2.5610
27
GO:0006325,chromatin organization 45 3.5 2.1 8.1610
23
GO:0016568,chromatin modification 29 2.3 1.8 1.0
aGeometric mean (in 2log scale) of the nominal p-values (not shown) for each GO category in a cluster.
bNumber of GO category genes in the blue module.
cPercentage of GO category genes in the blue module.
dFold Enrichment of genes in the blue modules compared to a background list.
eBonferroni corrected P-value for the enrichment of each GO category in the blue module.
doi:10.1371/journal.pgen.1002038.t004
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blue module genes in this category have been implicated in
osteoclastogenesis, such as Inpp5d (aka SHIP) [32], Smad5 [33], Id2
[34], Plcg2 [35], Twsg1 [36], among others. To test the hypothesis
that Asxl2 was involved in osteoclastogenesis, we infected bone
marrow macrophages (BMMs) with lentiviral constructs expressing
short-hairpin RNAs (shRNA) targeting Asxl2. BMMs were infected
with a vector only control (NC) or one of five lentiviral constructs
(A1–A5) expressing distinct shRNAs targeting Asxl2. After five
days of culture, Asxl2 expression was particularly lower in cells
infected with the A3 and A5 lentiviral constructs (Figure 6A).
Osteoclastogenesis was induced in infected BMMs by culturing in
the presence of M-CSF and RANKL. After five days of culture the
number of TRAP+ (tartrate-resistant acid phosphatase, a marker
of osteoclasts) multinuclear cells (MNCs) was significantly (P,0.05)
reduced in cultures infected with lentiviral constructs A3 and A5
compared to NC treated cells (Figure 6B and 6C). We observed a
strong positive correlation (r=0.74, P=0.04) between the relative
expression of Asxl2 and TRAP+ MNCs across the six treatments
(Figure 6D). These data are consistent with our network inference
and confirm that Asxl2 is a regulator of osteoclastogenesis and
strengthen the hypothesis that Asxl2 is a regulator of BMD.
Discussion
The mouse has numerous advantages for the genetic analysis of
BMD; however, historically mapping approaches in the mouse
have been plagued by the lack of resolution. Additionally, GWA
approaches provide no information on the function of associated
genes. We have addressed both limitations through the use of
high-resolution GWA in the HMDP to identify associations
confined to narrow genomic intervals and gene co-expression
analysis of bone microarray data to provide insight on gene
function. This novel analytical paradigm resulted in the discovery
of Asxl2 as a regulator of BMD and osteoclastogenesis. This study
identified a new gene and possibly an entire network of genes that
play an important role in BMD and osteoclast function.
Polycomb (PcG) and trithorax (trxG) are highly conserved
protein complexes that are involved in the repression and
activation of gene expression, respectively, through the establish-
ment and maintenance of chromatin modifications at specific
target genes [37]. With respect to bone cells, PcG and trxG have
been implicated in cell proliferation [38], myeloid precursor
maturation [39] and osteoblast differentiation [40]. In Drosophila,
Additional sex combs (Asx) belongs to a group of proteins known as the
Enhancers of trxG and PcG (ETP) [41]. Although its specific
mechanism is unknown, Asx is thought to promote both PcG-
mediated silencing and trxG-mediated activation of gene expres-
sion. In humans and mice there are three Asx homologues, Asx-like
1, 2 and 3 [42,43,44]. Mutations in ASXL1 result in myleopro-
liferative neoplasms [45] and little is known regarding the function
of ASXL3. Recently described Asxl2
2/2 knockout mice display a
global reduction in the PcG-associated histone modification
trimethylation of histone H3 lysine 27. This is consistent with a
conserved function as an ETP in mammals [31]. Additionally,
Asxl2
2/2 mice develop anterior and posterior transformations of
the axial skeleton [31], which further supports our observation that
Asxl2 is involved in bone development.
An important open question is whether Asxl2 impacts bone
development through its expression in other cell-types, such as
osteoblasts. If Asxl2 functioned exclusively in osteoclasts, we would
expect based on the in vitro osteoclastogenesis data, that loss of
Asxl2 function would impair osteoclast function and bone
resorption in vivo, resulting in increased BMD. In contrast, we
observed a decrease in BMD in Asxl2
2/2 mice. It has been shown
in a number of mouse models that loss of specific genes can lead to
an impairment of both osteoblast and osteoclast function. This
results in a condition referred to as low-turnover osteopenia in
which bone formation by osteoblasts and resorption by osteoclasts
are impaired with a net loss of bone. As examples, osteoblasts and
osteoclasts from mice deficient in klotho [46], JunB [47] and Akt1
[48] have impaired in vitro differentiation. These mice also have
reduced BMD due to low-turnover osteopenia. In addition,
Synaptotagmin VII (Syt11) has been shown to alter protein
secretion in osteoblasts and osteoclasts, resulting in decreased bone
mass in Syt
2/2 mice [49]. In data not presented we observed
(using publically available data from the BioGPS browser; http://
biogps.gnf.org, probes 1460597_at and 1439063_at) high and
ubiquitous expression of Asxl2 in 96 different mouse tissues and
cell-lines, including primary osteoclasts and osteoblasts. In
addition, while the blue module was highly enriched for genes
involved in myeloid differentiation there were also a number of
genes such as Bmp4, Chrd, Hdac5 and Igf2 that play a role in
osteoblast differentiation (Table S3). These data suggest that the
decreases in BMD seen in Asxl2
2/2 mice may be due to
deficiencies in both osteoclast and osteoblast function. Further
work is needed to clarify the precise role of Asxl2 in bone.
We have previously characterized the HMDP as a novel
population for GWA in the mouse [15]. This study extends our
original observations by demonstrating the feasibility of identifying
associations affecting additional complex phenotypes. In contrast
to more traditional mouse linkage mapping strategies, we used
association in the HMDP to identify four associations containing a
relatively small number of genes. Based on prior work, the
boundaries of the associations were defined as the 2.6 Mb region
surrounding the most significant SNP. We expect that these
intervals are conservative and would likely be smaller if based on
region specific LD patterns, as shown for Chr. 12 (Figure 3).
However, defining the associations in this way allowed us to be
confident that the regions contained the causal gene(s). This study
also highlights the other key advantage of the HMDP; the ability
to collect and molecularly profile tissues, such as bone, that are
difficult or impossible to collect from a single mouse or in human
populations. In the future, the accumulation of many bone-related
clinical and molecular phenotypes in the HMDP will enable the
large-scale systems-level analyses that should provide significant
insight on bone physiology and genetics. Additionally, the HMDP
will provide the opportunity to address the genetic basis of
extremely important phenotypes, such as bone loss, nanostrucutal
properties of bone and bone cell aging that are difficult to address
in humans. Moreover, as we have used systems genetic to gain
functional insight for a gene identified by mouse GWA, it is also
possible that the HMDP could be used to dissect the function of
genes identified in human GWA studies.
However, the HMDP is not without limitations. First, the
statistical power to detect effects of subtle variants is modest. We
have previously estimated that for highly heritable phenotypes,
such as BMD, the power to detect variants explaining 10% of the
trait variance is 50% [15]. The power drops precipitously for
variants explaining less than 10% of the variance. Thus, this
version of the HMDP (with ,100 strains) is unable to identify the
many more variants with subtle effects that are undoubtedly
affecting BMD in this population. This problem will be less of an
issue for future HMDP panels containing a larger number of
strains. Additionally, one of the side effects of the breeding history
of inbred mouse strains is the presence of LD between markers on
separate chromosomes (i.e. non-syntenic LD). It is thought that
this is due to selection for allelic combinations that confer
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PLoS Genetics | www.plosgenetics.org 10 April 2011 | Volume 7 | Issue 4 | e1002038Figure 6. Asxl2 is a regulator of osteoclastogenesis. (A) RT-PCR analysis of Asxl2 expression in BMMs infected with a control (NC) or five distinct
(A1–A5) lentiviral shRNA constructs targeting Asxl2. Numbers below construct names represent densitometrically determined relative Asxl2
expression ratios normalized for Actb. (B) TRAP staining of BMMs transduced with NC or one of the five (A1–A5) Asxl2 lentiviral shRNA constructs five
days after induction of osteoclast differention with M-CSF and RANKL. (C) Quantification of TRAP+ MNCs for cells shown in (B) (N=6/treatment). (D)
Relative expression of Asxl2 is positively correlated (r=0.74; P=0.04) with the number of TRAP+ MNCs across the five infections. Data shown in (C)
represents mean6SEM. *P,0.05.
doi:10.1371/journal.pgen.1002038.g006
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associations can arise if a region associated with a phenotype is in
LD with other regions of the genome. Although this is always a
potential pitfall when using the HMDP, it is easily identifiable and
we did not observe LD (r
2,0.4) between any of the four BMD
associations (data not shown).
Most GWA studies stop at gene discovery. However, without
physiologically relevant functional information it is often difficult
to be confident that the true causal gene has been identified and to
begin unraveling the mechanistic underpinnings of significant
associations. Recently, some GWA studies have begun to
incorporate gene expression information to determine if a
significant variant regulates expression. A positive finding in such
an analysis suggests that the genotype dependent differential gene
expression is the basis of the association. This approach has
recently been used to discover that variants in the promoter of the
serine racemase (SRR) gene regulate its expression and BMD [51].
We have taken that application one step further and developed a
bone transcriptional network to aid in the functional annotation of
genes of unknown function. Using this network, we were able to
determine that Asxl2 was closely connected to genes with links to
osteoclast differentiation. This simple connection allowed us to test
the hypothesis that Asxl2 was involved in a bone specific function.
Another important point is that, as we demonstrated for Asxl2,a
gene’s expression does not have to be under genetic regulation for
this approach to work.
In conclusion, we have used mouse GWA and gene co-
expression network analysis to identify Asxl2 as a novel regulator of
BMD and osteoclastogenesis. Our analysis has revealed a new
gene and pathway that play an important role in bone
development. Additionally, this study demonstrates the feasibility
of using the HMDP for the dissection of complex genetic traits.
Materials and Methods
Ethics statement
The animal protocol for the HMDP mice was approved by the
Institutional Care and Use Committee (IACUC) at the University
of California, Los Angeles. The animal protocol for the Asxl2
2/2
mice was approved by the Animal Care Committee (ACC) at the
University of Illinois at Chicago.
The Hybrid Mouse Diversity Panel
Approximately nine male mice for each HMDP strain (Table
S1) were purchased from the Jackson Labs (Bar Harbor, ME).
Mice were between 6 and 10 weeks of age and to ensure adequate
acclimatization to a common environment the mice were aged
until 16 weeks before sacrifice. All mice were maintained on a
chow diet (Ralston-Purina Co, St. Louis, Mo) until sacrifice.
Genotyping
Inbred strains were previously genotyped by the Broad Institute
(available via www.mousehapmap.org). Genotypes of recombinant
inbred strains were imputed as previously described [15]. Of the
140,000 SNPs available at the Broad Institute, 108,064 were
informative with an allele frequency $5% and less than 20%
missing data, and were used for the association analysis.
BMD determination
All carcasses were stored at 220uC after sacrifice and then
thawed overnight at 4uC prior to BMD scans. The entire thawed
carcass was scanned. BMD scans were performed using a Lunar
PIXImus II Densitometer (GE Healthcare, Piscataway, NJ). The
PIXImus II was calibrated daily using a phantom of known BMD.
BMD was calculated for the entire carcass minus the skull, the
lumbar spine and the left femur.
RNA and microarray processing
At sacrifice the diaphysis of the right femur was excised and
cleaned free of soft tissue. Bone marrow was removed by flushing
with PBS using a 22-guage needle and 3 ml syringe. The bone was
then flash frozen in LN2 and stored at 280C. Total RNA was
isolated using the Trizol Plus RNA Purification Kit (Invitrogen,
Carlsbad, CA) following homogenization of the whole bone
sample. RNA integrity was confirmed using the Agilent 2100
Bioanalyzer (Agilent, Palo Alto, CA). Microarray expression
profiles were generated (N=1–3 per strain) using the Illumina
MouseWG-6 v1.1 BeadChips (Illumina, San Diego, CA) by the
Southern Genotyping Consortium at UCLA. Biotin-labeled cRNA
was synthesized by the total prep RNA amplification kit from
Ambion (Austin, TX). cRNA was quantified and normalized to
77 ng/ml, and then 850 ng was hybridized to Beadchips.
Microarray data processing
The expression values were transformed using the Variance
Stabilizing Transformation (VST) [52], and normalized with the
Robust Spline Normalization (RSN) algorithm using the LumiR R
package [53]. After normalization, the ComBat software was used
to adjust for batch effects using an empirical Bayes methods [54].
Microarray data has been submitted the the NCBI Gene
Expression Omnibus (GEO) database (GSE27483).
EMMA
Population structure is a major confounding for genome-wide
association analyses in the HMDP. This is due to the fact that
many phenotypes correlate with the phylogeny of HMDP strains
(i.e. genetically similar strains have similar phenotypes) and any
SNP that correlates with these strain relationships will be falsely
associated with the phenotype. The Efficient Mixed-Model
Association (EMMA) algorithm has been shown to effectively
reduce this confounding [23]. We applied the following linear
mixed model to perform association mapping between BMD or a
gene’s expression and a marker under the confounding effect from
population structure [23,55,56]; y~mzbxzZuze, where y is a
phenotypes of each mouse, x is their genotype, Z is an incidence
matrix mapping each mouse to corresponding strain, u is a
random effect accounting for population structure effect with
Var(u)~s2
uK, and e is the uncorrelated random effect with
Var(e)~s2
eI. The Efficient Mixed Model Association (EMMA)
[23] is used for efficient and reliable estimation of restricted
maximum likelihood (REML) parameters and hypothesis testing
under the linear mixed model. After estimating REML parame-
ters, a standard F test is used to test the statistical significance of
the marker-phenotype association.
Candidate gene characterization
To characterize the genes located in each BMD association, we
downloaded all RefSeq genes in the four regions from the USCS
genome browser (http://genome.ucsc.edu/cgi-bin/hgGateway)
using the NCBI Build37 genome assembly. From the Illumina
MouseWG-6 microarray we identified all probes corresponding
to the 163 RefSeq genes. Probes were excluded if they overlapped
with SNPs (dbSNP 128) to avoid the hybridization artifacts that
can arise due [57,58]. EMMA was used to calculate association
P-values for all probes corresponding to the 163 RefSeq genes.
Only SNPs mapping to each associated region were used in this
analysis. Known non-synonymous SNPs within each region were
Association and Systems Genetics Analysis of BMD
PLoS Genetics | www.plosgenetics.org 12 April 2011 | Volume 7 | Issue 4 | e1002038downloaded from the Mouse Phenome Database (http://
phenome.jax.org/) using a set of over 7 million genotyped and
imputed SNPs. We only selected SNPs that were variant in at
least one of the classical inbred strains represented in the HMDP.
Prediction of the functional effect of these SNPs was performed
using the PolyPhen tool (http://genetics.bwh.harvard.edu/pph/).
R
2 was calculated for each non-synonymous SNP and the peak
BMD SNP within the 30 classical inbred strains in the HMDP.
Characterizing BMD in Asxl2
2/2 mice
The generation and initial characterization of Asxl2
2/2 gene trap
mice has been previously described [31]. These mice harbor a gene
trap cassette downstream of exon 1. Homozygotes for the gene trap
allele show little (,3%) Asxl2 expression whereas heterozygotes
expressed Asxl2 at ,50% of wild type levels. BMD in littermate male
and female mice (2–4 months of age) of varying Asxl2 genotype was
measured as described above. Age and weight at sacrifice were
recorded.To assessthe effects ofAsxl2deficiency onBMD independent
of age and weight we generated BMD residuals using a simple linear
regression. A Student’s t-test was used to test the significance of the
differences in BMD residuals in the different genotypes.
Weighted Gene Co-Expression Network Analysis
Network analysis was performed using the WGCNA R package
[59]. An extensive overview of WGCNA, including numerous
tutorials, can be found at http://www.genetics.ucla.edu/labs/
horvath/CoexpressionNetwork/. To begin, we filtered the array
data to remove lowly and non-expressed genes by selecting probes
based on a detection P-value of ,0.05 in 95% of the samples.
Next, we selected the 8000 most varying genes based on variance
across the 95 samples and then selected the most connected (based
on k.total described below) 3600 genes for network analysis. Our
group and others have used this number of genes previously (as
examples [19,60]), mainly because most other genes have very low
k.total values. If multiple probes existed for a given gene only the
most connected probe per gene was included in the list of 3600.
To generate a co-expression network for the selected probes, we
first calculated Pearson correlation coefficients for all gene-gene
comparisons across the 95 microarray samples. The matrix of
correlations was then converted to an adjacency matrix of
connection strengths. The adjacencies were defined as
aij~jcor(xi,xj)j
b where xi and xj are the ith and jth gene
expression traits. The power b was selected using the scale-free
topology criterion previously outlined by Zhang and Horvath [18].
Network connectivity (k.total) of the ith gene was calculated as the
sum of the connection strengths with all other network genes,
k:totali~
P
u=i
aiu. This summation performed over all genes in a
particular module was defined as the intramodular connectivity
(k.in). Modules were defined as sets of genes with high topological
overlap [18]. The topological overlap measure (TOM) between
the ith and jth gene expression traits was taken as TOM~ P
u=i,j
aiuaujzaij
min(k:totali,k:totalj)z1{aij
, where
P
u=i,j
aiuauj denotes the
number of nodes to which both i and j are connected, and u
indexes the nodes of the network. A TOM-based dissimilarity
measure (1{TOM) was used for hierarchical clustering. Gene
modules corresponded to the branches of the resulting dendro-
gram and were precisely defined using the ‘‘Dynamic Hybrid’’
branch cutting algorithm [61]. Highly similar modules were
identified by clustering and merged together. In order to
distinguish modules each was assigned a unique color.
Osteoclast culture and lentiviral transduction
Whole bone marrow was extracted from femora of mice with a-
MEM and cultured overnight in a-MEM (Sigma-Aldrich, St
Louis, MO) containing 10% heat-inactivated FBS, 100 IU/ml
penicillin, and 100 mg/ml streptomycin (a10 medium). The
nonadherent cells were collected by centrifugation and re-plated
in a new 10-cm petri dish in a10 medium. To generate osteoclasts,
100 ng/ml RANKL and 1/100 vol CMG 14-12 culture
supernatant were added to a10 medium for 4–5 days. Osteoclasts
were stained for TRAP as described by the manufacturer’s
instructions (Sigma-Aldrich). The SHCLNG-NM_172421 MIS-
SION lentiviral shRNA (Sigma-Aldrich) clone set (containing five
separate lentiviral shRNA clones each expressing a distinct Asxl2
targeting sequence) was used to transduce BMMs according to
manufacturer’s specifications. The MISSION pLKO.1-puro
control vector was used as a negative control.
Semi-quantitative RT-PCR
Total RNA was isolated from cultures using the RNeasy Mini Kit
(Qiagen). Purified RNA was DNase treated using the DNA-free kit
(Ambion). The High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems) was used to synthesize cDNA in a volume of
20 ml. The reaction mixture was adjusted to 200 ml with dH2Oa n d
5 ml of the dilute cDNA was used for PCR. PCR was performed for
22 cycles for Asxl2 and Actb using the following primers (Asxl2-F, 59-
ACCCACCATTCCAGCAAGTA-39, Asxl2-R, 59-TGGCTGC-
TTTGACAGTCTTG-39, Actb-F, 59-CCAACCGTGAAAAGA-
TGACC-39, Actb-R, 59-ACCAGAGGCATACAGGGACA-39).
PCR products were separated on a 1.5% agarose gel containing
0.5 mg/ml ethidium bromide. Band densitometry was performed
using the Image J software (NIH). Normalized Asxl2 expression
levels were determined by subtracting lane specific backgrounds for
each sample and dividing by Actb intensities.
Supporting Information
Figure S1 The expression of Asxl2 across HMDP strain is highly
variable. Asxl2 expression values from cortical bone (femoral
diaphysis with marrow removed) microarray data from 95 HMDP
strains. Asxl2 was highly expressed in bone and its expression
varies by 1.5-fold (log2 difference of 0.6) in the lowest and highest
expressing strains.
(PDF)
Table S1 List of individual BMD data points for all HMDP
mice used in the analysis.
(XLSX)
Table S2 List of eQTL mapping results for genes located within
the four BMD GWA associations. The local eQTL P-value
column contains the most significant association between the all
SNPs located within eac association and the expression of each
probe from the region. The overlapping SNP column contains the
number of SNPs that overlap each probe.
(XLSX)
Table S3 List of all non-synonymous SNPs within the 163 GWA
candidate genes. PolyPhen assignments; B, Benign; Poss D,
Possibly Damaging and Prob D, Probably Damaging. R
2 was
calculated for each NS SNP and the peak marker within its
respective region.
(XLSX)
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equals the correlation between the expression of each network
gene and Asxl2.
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Table S5 List of DAVID functional clusters with enrichment
scores .3.0 for the blue module.
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